An Observational Study of Octreotide Subcutaneous Depot in P... | Clinical Trial | StuddyBuddy@endsection An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07583563

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

Conditions: Acromegaly

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 200
Sponsor: Camurus AB

Location: Universitaetsklinikum Aachen Aachen

Summary

The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.

Eligibility Criteria

Inclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for acromegaly Exclusion Criteria: * Have started or will be starting treatment with octreotide SC depot for other conditions not related to acromegaly * Currently taking part in an interventional clinical trial or is still within a 30-day washout period from the end of taking part in an interventional clinical trial.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07583563). StuddyBuddy aggregates publicly available trial information.